Latest Shareholder Participation News

Page 2 of 48
Lithium Plus Minerals has opened a Share Purchase Plan seeking up to A$1 million from eligible Australian and New Zealand shareholders at A$0.10 a share. The funds are earmarked for the Lei Project’s pre-feasibility study, exploration and offtake discussions.
Maxwell Dee
Maxwell Dee
9 Nov 2026
OpenLearning has nearly tripled its placement to $430,000, taking commitments to its broader capital raising to $980,000 before the entitlement offer opens. The company could raise up to approximately $2.49 million, but the larger component remains dependent on shareholder participation.
Victor Sage
Victor Sage
9 Nov 2026
Solaris Australian Equity Income Plus is seeking up to $91.97 million through a placement and 1-for-3 entitlement offer priced below its market price. The capital is intended to enlarge the portfolio ahead of February and March dividend opportunities, but the offers are non-underwritten and non-renounceable.
Claire Turing
Claire Turing
9 Nov 2026
Sarytogan Graphite has launched a non-renounceable entitlement offer targeting up to $3.85 million, but only $1 million is underwritten and the issue depends on a Kazakh regulatory permit. The prospectus also flags going-concern uncertainty, substantial future project funding needs and dilution for shareholders who do not participate.
Maxwell Dee
Maxwell Dee
9 Nov 2026
Fulcrum Lithium has launched a non-underwritten share purchase plan seeking up to A$1.5 million at A$0.051 a share, a discount of about 20% to its recent five-day VWAP. The funds are earmarked for drilling and resource work at its Nevada lithium projects.
Maxwell Dee
Maxwell Dee
9 Nov 2026
X2M Connect has lodged a prospectus for a $3.6 million non-renounceable entitlement offer, with shareholders offered discounted shares, options and bonus shares. The raise is intended to fund technology and data centre initiatives, but the offer is not underwritten and the company warns that failure to complete it would create significant uncertainty over its ability to continue as a going concern.
Sophie Babbage
Sophie Babbage
9 Nov 2026
Embelton is seeking shareholder approval to leave the ASX, arguing that thin trading and annual listing costs of about $160,000 no longer justify the quotation. The company also proposes an $11 per share buy-back for other shareholders, subject to approval.
Victor Sage
Victor Sage
4 Nov 2026
Felix Gold has secured $7.25 million in placement commitments at a 14.3% discount and will seek a further $1 million from eligible shareholders. The funds will support mine permitting, refinery studies, drilling and resource work, but part of the raise still requires shareholder approval.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Far East Gold has opened a non-underwritten share purchase plan offering eligible shareholders new shares at A$0.10, a discount of up to 20% to recent trading levels. The proceeds are intended to support working capital and advance the Idenburg project, although the final amount raised remains uncertain.
Maxwell Dee
Maxwell Dee
3 Nov 2026
Cynata Therapeutics will raise approximately $912,962 after shareholders subscribed for just 25.8% of its fully underwritten entitlement offer. Caravel Securities will fund the remaining shortfall, leaving the biotech reliant on the underwriter to complete the raise.
Ada Torres
Ada Torres
30 Oct 2026
Andromeda Metals has produced 99.9986% purity High Purity Alumina at continuous pilot scale and raised A$3.04 million to advance its next study. But the Great White Project still needs about A$40 million in equity before a final investment decision.
Maxwell Dee
Maxwell Dee
28 Oct 2026
L1 Global Long Short Fund has completed its entitlement offer, shortfall offers and institutional placement, raising the maximum A$565.4 million available. The capital will be invested under the L1 Global Long Short Strategy, with 321.2 million new shares due to begin trading next week.
Claire Turing
Claire Turing
27 Oct 2026

Browse the archive

Full archive